The forecast for the number of multidrug-resistant tuberculosis cases started on treatment in France shows a steady increase from 2024 to 2028, with cases expected to rise from 96 in 2024 to 105 in 2028. This represents a consistent year-on-year growth rate of approximately 2% over this period. The Compound Annual Growth Rate (CAGR) from 2024 to 2028 would also approximate this growth, indicating stability in the upward trend of cases receiving treatment.
Future trends to watch for include:
- Developments in preventive and curative treatments that could affect case numbers.
- Changes in healthcare policies and funding impacting tuberculosis control efforts.
- Global health trends that might influence domestic cases and treatment protocols.
